IT security company Imprivata picked up critical access management firm SecureLink to expand its cybersecurity solutions for healthcare. The deal, first announced Feb. 23, values the combined health care technology company at approximately $3.5 billion, Axios' Sarah Pringle reports. Software investment firm Thoma Bravo acquired Imprivata in 2016 in a deal valued at approximately $544 million.

There is certainly no shortage of articles being written about cybersecurity, the evolving security threats presented by a remote workforce or the proliferation of devices used to access data that make the security of data increasingly vulnerable. There is also no shortage of suggestions about how to mitigate risk for organizations. And yet, in many ways, those topics often seem more like concepts and less like risk warnings. The reality is that we are at risk, that the risk is growing exponentially and that those who target information rely on complacency to succeed.

Mark McArdle is Chief Products and Design Officer at IT security leader, Imprivata. The company has worked within healthcare for two decades. Its Imprivata OneSign, FairWarning and virtual smartcard solutions are helping to secure NHS hospitals across the UK. Mark is himself an industry veteran, with a cybersecurity career stretching back to the early ‘90s. Health Tech World got in touch with Mark to learn more about digital identity and how the pandemic has accelerated innovation.

Imprivata Wins Multiple Awards in Identity and Access Management at 10th Annual Global InfoSec Awards at #RSAC 2022